Elevated Topoisomerase I Activity in Cervical Cancer as a Target for Chemoradiation Therapy

Author： Chen B.-M.   Chen J.-Y.   Kao M.   Lin J.-B.   Yu M.-H.   Roffler S.R.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.79, Iss.2, 2000-11, pp. : 272-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1001-1006

Science Publishers

Access to resources Recommend Favorite

Optimizing Treatment for Cervical Cancer: The Value of Chemoradiation

By John A. Green  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 215-227

Adis International

Access to resources Recommend Favorite

DNA-Topoisomerase I, a new target for the treatment of neuroblastoma

By Vassal G.   Pondarre C.   Cappelli C.   Terrier-Lacombe M.J.   Boland I.   Morizet J.   Benard J.   Venuat A.M.   Ardouin P.   Hartmann O.   Gouyette A.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2011-2015

Elsevier

Access to resources Recommend Favorite

Phase I Study of Topotecan and Radiation Therapy in Advanced Cervical Cancer

By Dunton C.J.   King S.A.   Neufeld J.   Tolosa J.   Perez G.   Avila A.   Underhill K.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 185-187

Elsevier

Access to resources Recommend Favorite

Cytochrome P450 3A-mediated metabolism of the topoisomerase I inhibitor 9-aminocamptothecin: Ιmpact on cancer therapy

By              

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 877-886

Spandidos Publications

Access to resources Recommend Favorite